News | September 09, 2025
Alcon India launches Unity VCS/CS for vitreoretinal and cataract surgery
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
At the center of the collapse is opposition from the Federal Trade Commission
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision with high best-in-category contrast & low-light performance
The approved ANDA is therapeutically equivalent to the reference listed drug product
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Bromfenac Ophthalmic Solution 0.075% (RLD BromSite) had estimated annual sales of USD 15 million in the U.S.
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Subscribe To Our Newsletter & Stay Updated
